Ampio Pharma (AMPE) Reports Positive Results in OptimEyes Trial of Optina for DME
Tweet Send to a Friend
Ampio Pharmaceuticals, Inc. (NYSE: AMPE) today announced positive results of the OptimEyes trial for DME. The OptimEyes trial was a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
